As a Clinician

Mark T. Gladwin, MD completed his internship and chief residency in internal medicine at the Oregon Health Sciences University, followed by a critical care medicine fellowship at the National Institutes of Health (NIH) in Bethesda, and a pulmonary fellowship at the University of Washington in Seattle.

Dr. Gladwin's career has included serving in the roles of physician-scientist, clinician, educator, and academic leader at two institution — the University of Pittsburgh and the NIH. At both institutions, he was consistently promoted to greater responsibility and leadership, building new programs and improving existing ones. At NIH, he served as critical care fellow, senior research  fellow section head for the Sickle Cell Nitric Oxide Therapeutic and Vascular Therapeutics sections, director of the functional genomics core, and Chief of the Pulmonary and Vascular Medicine Branch of the National Heart, Lung, and Blood Institute. In 2008, Dr. Gladwin was recruited to the University of Pittsburgh to serve as Chief of the Division of Pulmonary, Allergy and Critical Care Medicine (PACCM) and the inaugural Director of the Vascular Medicine Institute.

He assumed the role of Department Chair in 2014, overseeing more than 800 faculty (including 120 PhD faculty and an additional >170 advanced practice providers) and combined clinical and research revenues approaching $300 million. During his tenure the Department's NIH funding increased by more than 25 percent, and has been ranked in the top 10 funded Departments of Medicine in NIH funding for the last four years, according to the Blue Ridge Institute for Medical Research.

At the University of Pittsburgh Medical Center, Dr. Gladwin worked to establish clinical programs to increase patient access to quality care and supported the development of signature programs in clinical analytics, telemedicine, E-consultation, critical care, specialty and hospitalist services, and multidisciplinary Clinical Centers of Excellence across 10 divisions.

As the Department of Medicine chair, he also supported the development of a long list of research centers of excellence, including in aging, vascular biology, the microbiome, metabolism, mitochondrial biology, antibody therapeutics, and sickle cell research, the latter of which has been a focus of Dr. Gladwin's own research for more than 20 years. Dr. Gladwin credits his leadership success to careful listening and fact finding, the recruitment and partnership with strong leaders, the use of analytics to measure performance and provide feedback, and the thoughtful alignment of incentives to galvanize stakeholder support and sustainability.

Dr. Gladwin is a member of the American Osteopathic Association, the American Society for Clinical Investigation (ASCI), the Association of Professors of Medicine (APM), and the Association of American Physicians, and has served on the ASCI and APM councils. He is a Fellow of the American College of Physicians, American Heart Association, Association of American Physicians (AAP), and Pulmonary Vascular Research Institute. He has received numerous academic awards including the U.S. Public Health Service Achievement Award, the NIH Director's Award for Mentoring, the NIH Clinical Center Director's Award for Science, the NIH Merit Award in recognition for accomplishments in both basic and clinical sciences, the Recognition Award for Scientific Accomplishments from the American Thoracic Society, was named an American Heart Association Distinguished Scientist, and was recognized as Distinguished Professor at the University of Pittsburgh 2014.